194 related articles for article (PubMed ID: 28677246)
1. Factor XI-deficient mice exhibit increased bleeding after injury to the saphenous vein.
Ay C; Hisada Y; Cooley BC; Mackman N
J Thromb Haemost; 2017 Sep; 15(9):1829-1833. PubMed ID: 28677246
[TBL] [Abstract][Full Text] [Related]
2. Factor XI promotes hemostasis in factor IX-deficient mice.
Mohammed BM; Cheng Q; Matafonov A; Monroe DM; Meijers JCM; Gailani D
J Thromb Haemost; 2018 Oct; 16(10):2044-2049. PubMed ID: 30007049
[TBL] [Abstract][Full Text] [Related]
3. The hemostatic role of factor XI.
Puy C; Rigg RA; McCarty OJ
Thromb Res; 2016 May; 141 Suppl 2(Suppl 2):S8-S11. PubMed ID: 27207433
[TBL] [Abstract][Full Text] [Related]
4. Congenital factor XI deficiency: an update.
Duga S; Salomon O
Semin Thromb Hemost; 2013 Sep; 39(6):621-31. PubMed ID: 23929304
[TBL] [Abstract][Full Text] [Related]
5. Plasma Kallikrein Contributes to Coagulation in the Absence of Factor XI by Activating Factor IX.
Visser M; van Oerle R; Ten Cate H; Laux V; Mackman N; Heitmeier S; Spronk HMH
Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):103-111. PubMed ID: 31766871
[TBL] [Abstract][Full Text] [Related]
6. Gene targeting in hemostasis. factor XI.
Gailani D
Front Biosci; 2001 Feb; 6():D201-7. PubMed ID: 11171549
[TBL] [Abstract][Full Text] [Related]
7. Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency.
Zucker M; Seligsohn U; Salomon O; Wolberg AS
J Thromb Haemost; 2014 Jul; 12(7):1121-30. PubMed ID: 24815347
[TBL] [Abstract][Full Text] [Related]
8. Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway.
Colucci M; Incampo F; Cannavò A; Menegatti M; Siboni SM; Zaccaria F; Semeraro N; Peyvandi F
J Thromb Haemost; 2016 Aug; 14(8):1603-14. PubMed ID: 27094709
[TBL] [Abstract][Full Text] [Related]
9. Tissue Factor-Independent Coagulation Correlates with Clinical Phenotype in Factor XI Deficiency and Replacement Therapy.
Bertaggia Calderara D; Zermatten MG; Aliotta A; Batista Mesquita Sauvage AP; Carle V; Heinis C; Alberio L
Thromb Haemost; 2021 Feb; 121(2):150-163. PubMed ID: 32920807
[TBL] [Abstract][Full Text] [Related]
10. Characterization of hereditary factor XI deficiency in Taiwanese patients: identification of three novel and two common mutations.
Lin HY; Lin CY; Hung MH; Kuo SF; Lin JS; Shen MC
Int J Hematol; 2020 Aug; 112(2):169-175. PubMed ID: 32333264
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor pathway inhibitor is a potential modifier of bleeding risk in factor XI deficiency.
Reitsma SE; Holle LA; Bouck EG; Monroe DM; Mast AE; Burthem J; Bolton-Maggs PHB; Gidley GN; Wolberg AS
J Thromb Haemost; 2023 Mar; 21(3):467-479. PubMed ID: 36696199
[TBL] [Abstract][Full Text] [Related]
12. Coagulation factor XI improves host defence during murine pneumonia-derived sepsis independent of factor XII activation.
Stroo I; Zeerleder S; Ding C; Luken BM; Roelofs JJTH; de Boer OJ; Meijers JCM; Castellino FJ; van 't Veer C; van der Poll T
Thromb Haemost; 2017 Jul; 117(8):1601-1614. PubMed ID: 28492700
[TBL] [Abstract][Full Text] [Related]
13. Coagulation factor XI as a novel target for antithrombotic treatment.
Löwenberg EC; Meijers JC; Monia BP; Levi M
J Thromb Haemost; 2010 Nov; 8(11):2349-57. PubMed ID: 20727068
[TBL] [Abstract][Full Text] [Related]
14. The impact of thrombin generation and rotation thromboelastometry on assessment of severity of factor XI deficiency.
Livnat T; Shenkman B; Martinowitz U; Zivelin A; Dardik R; Tamarin I; Mansharov R; Budnik I; Salomon O
Thromb Res; 2015 Aug; 136(2):465-73. PubMed ID: 26160656
[TBL] [Abstract][Full Text] [Related]
15. Two novel inhibitory anti-human factor XI antibodies prevent cessation of blood flow in a murine venous thrombosis model.
van Montfoort ML; Knaup VL; Marquart JA; Bakhtiari K; Castellino FJ; Hack CE; Meijers JC
Thromb Haemost; 2013 Nov; 110(5):1065-73. PubMed ID: 23925504
[TBL] [Abstract][Full Text] [Related]
16. The dimeric structure of factor XI and zymogen activation.
Geng Y; Verhamme IM; Smith SB; Sun MF; Matafonov A; Cheng Q; Smith SA; Morrissey JH; Gailani D
Blood; 2013 May; 121(19):3962-9. PubMed ID: 23515926
[TBL] [Abstract][Full Text] [Related]
17. Novel mouse hemostasis model for real-time determination of bleeding time and hemostatic plug composition.
Getz TM; Piatt R; Petrich BG; Monroe D; Mackman N; Bergmeier W
J Thromb Haemost; 2015 Mar; 13(3):417-25. PubMed ID: 25442192
[TBL] [Abstract][Full Text] [Related]
18. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo.
Cheng Q; Tucker EI; Pine MS; Sisler I; Matafonov A; Sun MF; White-Adams TC; Smith SA; Hanson SR; McCarty OJ; Renné T; Gruber A; Gailani D
Blood; 2010 Nov; 116(19):3981-9. PubMed ID: 20634381
[TBL] [Abstract][Full Text] [Related]
19. Factor XI Deficiency Protects Against Atherogenesis in Apolipoprotein E/Factor XI Double Knockout Mice.
Shnerb Ganor R; Harats D; Schiby G; Gailani D; Levkovitz H; Avivi C; Tamarin I; Shaish A; Salomon O
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):475-81. PubMed ID: 26800563
[TBL] [Abstract][Full Text] [Related]
20. The Management of Factor XI Deficiency in Pregnancy.
Davies J; Kadir R
Semin Thromb Hemost; 2016 Oct; 42(7):732-740. PubMed ID: 27699729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
